Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve the Un-Audited Standalone And Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026

October 23, 2026 BSE Limited National Stock Exchange of India Limited P. J. Towers, Exchange Plaza, Dalal Street, Bandra-Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code-540025 Trading Symbol-ADVENZYMES Dear Sir/Madam, Sub: Intimation of Board Meeting and closure of Trading Window. This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, October 31, 2026, inter alia, to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026. Closure of Trading Window: Further to our letter dated September 28, 2026 intimating closure of Trading Window, and in connection with the above, we wish to inform you that the “Trading Window” for dealing in the Securities of the Company will continue to remain closed up to November 02, 2026. Copy of this intimation / notice is also being uploaded on the website of the Company at www.advancedenzymes.com and can be accessed on the website of the Stock Exchanges i.e. www.bseindia.com and www.nseindia.com. Kindly take the above on record. Thanking you, For Advanced Enzyme Technologies Limited Sanjay Basantani Company Secretary and Head – Legal